Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

Nabi Biopharmaceuticals News

Most Popular Nabi Biopharmaceuticals Story

Nabi explores options after NicVAX flunks trial

November 9, 2011 — 2:51pm ET | By Maureen Martino

Nabi Biopharmaceuticals ($NABI) was hit hard earlier this week after the company's smoking cessation vaccine NicVAX flunked a second late-stage trial. Data showed the primary endpoint was not met in Read more...

Nabi Biopharmaceuticals Press Releases

Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial
Dr. Ali Fattom Joins NanoBio to Lead the Company’s Vaccine Research Efforts
Mtech Bioprocess Scale-Up Facility to Double in Staff and Size, Expand to Shady Grove, Create Pilot Plant for Biofuels in Colleg
Nabi Biopharmaceuticals Completes Third PentaStaph(TM) Milestone

Latest Headlines

Nabi explores options after NicVAX flunks trial
November 9, 2011
NicVAX failure spells trouble for Nabi
July 21, 2011
Nabi lands $10M for anti-smoking vaccine
September 29, 2009
Nabi, FDA agree on SPA for NicVAx
December 23, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK